MENU
+Compare
CDXS
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$2.11
Change
-$0.01 (-0.47%)
Capitalization
174.79M

CDXS Codexis Forecast, Technical & Fundamental Analysis

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes... Show more

CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CDXS with price predictions
Apr 17, 2025

CDXS sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CDXS moved below the 200-day moving average on April 01, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CDXS as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CDXS entered a downward trend on April 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CDXS's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where CDXS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CDXS just turned positive on April 11, 2025. Looking at past instances where CDXS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

CDXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.624) is normal, around the industry mean (13.448). P/E Ratio (0.000) is within average values for comparable stocks, (63.132). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.755). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (2.623) is also within normal values, averaging (251.200).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CDXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CDXS is expected to report earnings to rise 82.08% to -23 cents per share on May 01

Codexis CDXS Stock Earnings Reports
Q1'25
Est.
$-0.24
Q4'24
Missed
by $0.09
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.06
Q1'24
Beat
by $0.02
The last earnings report on February 27 showed earnings per share of -12 cents, missing the estimate of -3 cents. With 557.17K shares outstanding, the current market capitalization sits at 174.79M.
A.I. Advisor
published General Information

General Information

a developer of biocatalytic chemical processes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMGYX23.470.10
+0.43%
Macquarie Mid Cap Growth Y
DFMAX30.62N/A
N/A
Davidson Multi-Cap Equity A
IALAX31.92N/A
N/A
Transamerica Capital Growth A
FHUMX13.24N/A
N/A
Federated Hermes US SMID Institutional
MBINX29.62-0.02
-0.07%
NYLI Balanced Investor Class

CDXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
-0.47%
DNLI - CDXS
49%
Loosely correlated
+1.51%
ABCL - CDXS
47%
Loosely correlated
+1.26%
PRAX - CDXS
44%
Loosely correlated
+13.29%
XENE - CDXS
43%
Loosely correlated
+3.94%
AXON - CDXS
43%
Loosely correlated
-2.15%
More